Immunotherapy from malignant disease.
D001500:BCG Vaccine / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000628:therapy; D001943:Breast Neoplasms / Q000628:therapy; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000628:therapy; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000628:therapy; D005833:Genital Neoplasms, Female / Q000628:therapy; D005834:Genital Neoplasms, Male / Q000628:therapy; D006801:Humans; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy / Q000379:methods; D007938:Leukemia; D007978:Levamisole / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008545:Melanoma / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D011425:Propionibacterium acnes; D012004:Rectal Neoplasms / Q000628:therapy; D012107:Research Design; D012509:Sarcoma / Q000628:therapy; D012878:Skin Neoplasms / Q000628:therapy
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D007978:Levamisole